Page 30 - Predicting survival in patients with spinal bone metastasesL

CHAPTER II REFERENCES
1. Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin 2007;57:43-66
2. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression. J. Clin. Oncol. 2005;23(9):2028-37
3. Mizumoto M, Harada H, Asakura H, et al. Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int J Radiat Oncol Biol Phys. 2011;79(1):208-13.
4. Bollen L, van der Linden YM, Pondaag W, et al. Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1 043 patients. Neuro-oncol. 2014;16(7):991-998.
5. Rades D, Hueppe M, Schild SE. A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care. Cancer. 2013;119(4):897-903.
6. Helweg-Larsen S, Sørensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys. 2000;46(5):1163–1169.
7. Bach F, Larsen BH, Rohde K, et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir. 1990;107(1-2):37–43.
8. Van der Linden YM, Dijkstra PDS, Vonk E, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. 2005;103(2):320–8.
9. Chow E, Harth T, Hruby G, et al. How accurate are physicians’ clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol. 2001;13(3):209–18.
10. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186–91.
11. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine. 2001;26(3):298– 306.
12. Leithner A, Radl R, Gruber G, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur. Spine .J. 2008; 17(11): 1488–95.
13. Bollen L, Wibmer C, Van der Linden YM, et al. Predictive value of six prognostic scoring systems for spinal bone metastases: an analysis based on 1379 patients. Spine. 2016;41(3):155-62.
14. Hayden JA, Van der Windt DA, Cartwright JL, et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280-286.
15. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. with particular reference to bronchogenic carcinoma. Cancer. 1948;(1):634- 656.
16. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982;5(6):649-55.
17. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Spinal Cord. 1969;7(3):179–92.
18. Ariëns GA, Van Mechelen W, Bongers PM, et al. Physical risk factors for neck pain. Scand J Work Environ Health. 2000;26(1):7-19.
19. Scholten-Peeters GG, Verhagen AP, Bekkering GE, et al. Prognostic factors of whiplash associated disorders: a systematic review of prospective cohort studies. Pain. 2003;104(1-2):303-322.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
21. Riegel T, Schilling T, Sitter H, et al. Analysis of factors affecting the prognosis of vertebral metastases. Zentralbl Neurochir 2002;63(1),2-6.
22. Hosono N, Ueda T, Tamura D, et al. Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop Relat Res. 2005;(436):196-201.
28